Shots:
Did you know that patients living with SLE in the EU face a two- to threefold higher risk of mortality compared to the general population? This stark reality underscores the need for therapies that are not only effective but also easier to administerÂ
AstraZeneca’s Saphnelo has recently been recommended for approval in the EU as a…
